These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10919184)

  • 1. [Acute pharmacological test with clonidine for the tremor in patients with Parkinson disease].
    Serrano-Dueñas M
    Rev Neurol; 2000 May 16-31; 30(10):910-3. PubMed ID: 10919184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute pharmacological test of clonidine in essential tremor].
    Serrano Dueñas M
    Neurologia; 1997 Jan; 12(1):9-11. PubMed ID: 9131917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors predicting response to dopaminergic treatment for resting tremor of Parkinson's disease.
    Sung YH; Chung SJ; Kim SR; Lee MC
    Mov Disord; 2008 Jan; 23(1):137-40. PubMed ID: 17987649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of subthalamic nucleus stimulation and medication on resting and postural tremor in Parkinson's disease.
    Sturman MM; Vaillancourt DE; Metman LV; Bakay RA; Corcos DM
    Brain; 2004 Sep; 127(Pt 9):2131-43. PubMed ID: 15240437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of acute levodopa challenge for clinical prediction of sustained long-term levodopa response as a major criterion for idiopathic Parkinson's disease diagnosis.
    Merello M; Nouzeilles MI; Arce GP; Leiguarda R
    Mov Disord; 2002 Jul; 17(4):795-8. PubMed ID: 12210878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of subcutaneous apomorphine on tremor in idiopathic Parkinson's disease.
    Hellmann MA; Sabach T; Melamed E; Djaldetti R
    Biomed Pharmacother; 2008; 62(4):250-2. PubMed ID: 17967525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral beta-adrenergic blockade treatment of parkinsonian tremor.
    Foster NL; Newman RP; LeWitt PA; Gillespie MM; Larsen TA; Chase TN
    Ann Neurol; 1984 Oct; 16(4):505-8. PubMed ID: 6149724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's disease.
    Happe S; Tings T; Helmschmied K; Neubert K; Wuttke W; Paulus W; Trenkwalder C
    Mov Disord; 2004 Dec; 19(12):1511-5. PubMed ID: 15390061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clonidine versus propranolol in the treatment of essential tremor. A double-blind trial with a one-year follow-up].
    Serrano-Dueñas M
    Neurologia; 2003 Jun; 18(5):248-54. PubMed ID: 12768510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histories of sexual abuse are associated with differential effects of clonidine on autonomic function in women with premenstrual dysphoric disorder.
    Bunevicius R; Hinderliter AL; Light KC; Leserman J; Pedersen CA; Girdler SS
    Biol Psychol; 2005 Jul; 69(3):281-96. PubMed ID: 15925031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and treatment of tremor in Parkinson's disease and essential tremor].
    Wolters A; Benecke R
    MMW Fortschr Med; 2007 May; 149 Suppl 2():94-6. PubMed ID: 17724978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effectiveness and tolerance of piribedil as adjunct therapy to levodopa in patients with Parkinson's disease: a nine month follow up].
    Salazar Tortolero G; Wix Ramos R; Salazar Aladrén P; Jiménez León JC
    Rev Neurol; 2004 Apr 16-30; 38(8):715-9. PubMed ID: 15122540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of rivastigmine on tremor in patients with Parkinson's disease and dementia.
    Gurevich TY; Shabtai H; Korczyn AD; Simon ES; Giladi N
    Mov Disord; 2006 Oct; 21(10):1663-6. PubMed ID: 16941467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tremor in Parkinson's disease: 24-hr monitoring with calibrated accelerometry.
    Thielgen T; Foerster F; Fuchs G; Hornig A; Fahrenberg J
    Electromyogr Clin Neurophysiol; 2004; 44(3):137-46. PubMed ID: 15125053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Parkinson's disease: levodopa as the first choice.
    Katzenschlager R; Lees AJ
    J Neurol; 2002 Sep; 249 Suppl 2():II19-24. PubMed ID: 12375059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
    Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
    Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potentials of centrally acting dopamine and alpha 2-adrenoreceptor agonists.
    Goldstein M; Engel J; Lieberman A; Regev I; Bystritsky A; Mino S
    J Neural Transm Suppl; 1983; 18():257-63. PubMed ID: 6135744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Utility of the study of the vegetative nervous system in the differential diagnosis between Parkinson's disease and multiple system atrophy].
    Rouco I; Gómez JC; Lezcano E; Aniel-Quiroga MA; Velasco F; Barcena J; Pérez Bas M; Hurtado P; Cruz Lachén M; Zarranz JJ
    Neurologia; 2006 Apr; 21(3):119-23. PubMed ID: 16575624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of methylphenidate on response to oral levodopa: a double-blind clinical trial.
    Nutt JG; Carter JH; Carlson NE
    Arch Neurol; 2007 Mar; 64(3):319-23. PubMed ID: 17353373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuronal activities in the ventrolateral thalamus and basal ganglia in relation to Parkinson's disease].
    Wang J; Zhuang P; Li YJ
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(15):1021-6. PubMed ID: 16784702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.